To do this it costs lab space, it costs machines that easily go in the millions, it costs sweat and tears of scientists, it takes the lives of many generations of scientists sometimes. The stakes are already high for those who take on these projects. Already, we have a problem with PhDs in the health sciences field making shit money. You want to further discourage them into going in this field by denying them what little they get now? So that they rather make easy money serving you ads based on the information they've gotten from observing your habits?
exactly the same as in tech - founders reap the big rewards, individual coders less so.
http://pipeline.corante.com/archives/2010/11/04/where_drugs_...
58% from pharmaceutical companies.
18% from biotech companies..
16% from universities, transferred to biotech.
8% from universities, transferred to pharma.
Pharma and biotech companies do develop some drugs themselves, but the majority model is for a start-up to form around a single drug, and if it looks promising a big player buys them up to finish testing and then market it. If the drug looks promising the company is killed.
Venture capital is basically doing the job of drug discovery.
But I suspect the reality is different. I can imagine a couple of reasons for low salaries: Big Pharma would like nothing more than pay its personnel decently, but they're barely breaking even. Alternatively, the ratio between PhDs and jobs available doesn't work in the favour of PhDs. In which case, Big Pharma making even more money would translate into additional mansions for C-level executives, not better salaries for PhDs.
Which explanation do you feel is the most likely?
That said, yes, I think the health sector should be state-run and not operate with a profit motive, but whether or not you agree or with this idea doesn't change the fact that your comparison is flawed.